Tykhe Corp
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
Tykhe Corp (HALB) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of July 2024: 0.001x
Based on the latest financial reports, Tykhe Corp (HALB) has a cash flow conversion efficiency ratio of 0.001x as of July 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-531.00) by net assets ($-718.59K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tykhe Corp - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Tykhe Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Tykhe Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tykhe Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kings Arms Yard Vct Plc
LSE:KAY
|
-0.003x |
|
Topcon Corporation
PINK:TOPCF
|
12.965x |
|
Naeem Holding
EGX:NAHO
|
N/A |
|
Paragon Shipping Inc
PINK:PRGNF
|
0.083x |
|
Australian Oil & Gas Corporation
PINK:AOGC
|
-0.122x |
|
GAS2GRID
BE:GT4
|
N/A |
|
Buyer Group International Inc
PINK:BYRG
|
0.010x |
|
ASO SAVINGS AND LOANS PLC
XNSA:ASOSAVINGS
|
N/A |
Annual Cash Flow Conversion Efficiency for Tykhe Corp (2008–2024)
The table below shows the annual cash flow conversion efficiency of Tykhe Corp from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-07-31 | $-718.59K | $-51.64K | 0.072x | -72.35% |
| 2023-07-31 | $-926.37K | $-240.74K | 0.260x | -79.45% |
| 2022-07-31 | $-727.91K | $-920.33K | 1.264x | -20.33% |
| 2021-07-31 | $-485.36K | $-770.30K | 1.587x | +962.59% |
| 2020-07-31 | $-284.98K | $-42.56K | 0.149x | +14050.40% |
| 2017-07-31 | $-622.45K | $-657.00 | 0.001x | +120.60% |
| 2016-07-31 | $-629.09K | $-301.00 | 0.000x | +101.54% |
| 2011-07-31 | $-429.48K | $13.35K | -0.031x | -112.96% |
| 2010-07-31 | $-879.27K | $-210.77K | 0.240x | +247.90% |
| 2009-07-31 | $-615.24K | $99.71K | -0.162x | +60.74% |
| 2008-07-31 | $-36.09K | $14.90K | -0.413x | -- |